In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
 

EHJ - Cardiovascular Pharmacotherapy

Specific focus on clinical cardiovascular pharmacology

 

The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is the official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy. The journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area.

It publishes original articles concerning clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews.

Access your online journal

 

Fast Facts

  • Editor-in-Chief: Stefan Agewall FESC, NO
  • Current volume: 5 (year 2019)
  • Issues per subscription: 4

Subscriptions

Subscribe

Connect with us on Twitter

@ESC_Journals
Updates on latest articles

Updates on latest articles

 

Receive Table of contents in your mailbox.

Track the topics, authors and articles important to you and receive articles in your mailbox.

Sign up

For Authors

Before being published, all manuscripts go through double-blinded peer review by experienced international experts.

Submit a Manuscript

Submit

Instructions for Authors

Find out more

Publisher Information

See more

Frequently Asked Questions

See more

Most recent articles from EHJ-CVP

14 Mar 2019
European Heart Journal – Cardiovascular Pharmacotherapy: now accepted for an official Impact Factor
Author(s):Agewall S.
14 Mar 2019
Corrigendum to: Adherence to dabigatran etexilate in atrial fibrillation patients intended to undergo electrical cardioversion
14 Mar 2019
Unsolved issues in oral anticoagulation treatment in atrial fibrillation
Author(s):Agewall S.
01 Feb 2019
Ivabradine for heart failure: regulatory differences in Europe and United States
Author(s):Marciniak T, Hall T, Atar D, et al.

 

 
About the ESC
Press and Media
Information
Follow us

         

 Contact us

© 2018 European Society of Cardiology. All rights reserved